NGNE Competitors & Alternatives
Compare Neurogene Inc with similar stocks in the same industry
Biotechnology
NGNE
Main Stock$24.28
Tradestie Score
53
Market Cap
$256.54M
Analyst Upside
+220.7%
Top Competitors
220 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
CTMX
CytomX Therapeutics, Inc.
|
$2.44
|
$552.46M | - | 66 | Compare |
|
VSTM
Verastem, Inc.
|
$10.06
|
$541.60M | - | 44 | Compare |
|
CRVS
Corvus Pharmaceuticals, Inc.
|
$10.65
|
$540.97M | - | 57 | Compare |
|
ZVRA
Zevra Therapeutics, Inc. Common Stock
|
$10.33
|
$529.35M | 11.4 | 61 | Compare |
|
LXRX
Lexicon Pharmaceuticals, Inc.
|
$1.49
|
$512.39M | - | 65 | Compare |
|
RIGL
Rigel Pharmaceuticals Inc. (New)
|
$48.86
|
$505.12M | 2.8 | 56 | Compare |
|
INBX
Inhibrx Biosciences, Inc. Common Stock
|
$97.10
|
$492.21M | - | 65 | Compare |
|
XOMA
XOMA Royalty Corporation Common Stock
|
$40.17
|
$474.20M | 28.2 | 46 | Compare |
|
ABSI
Absci Corporation Common Stock
|
$9.37
|
$468.01M | - | 58 | Compare |
|
GLUE
Monte Rosa Therapeutics, Inc. Common Stock
|
$11.11
|
$463.20M | - | 45 | Compare |
More NGNE Analysis
Data updated: Oct 23, 2026 | Industry: Biotechnology (SIC 2834)
220 stocks in this industry